KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Interest Coverage Ratio: 2017-2025

Historic Interest Coverage Ratio for Aquestive Therapeutics (AQST) over the last 9 years, with Sep 2025 value amounting to -4.13.

  • Aquestive Therapeutics' Interest Coverage Ratio fell 38.52% to -4.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -5.02, marking a year-over-year decrease of 152.37%. This contributed to the annual value of -2.77 for FY2024, which is 16.09% down from last year.
  • According to the latest figures from Q3 2025, Aquestive Therapeutics' Interest Coverage Ratio is -4.13, which was down 1.05% from -4.09 recorded in Q2 2025.
  • Aquestive Therapeutics' Interest Coverage Ratio's 5-year high stood at 0.02 during Q2 2024, with a 5-year trough of -7.81 in Q2 2022.
  • Over the past 3 years, Aquestive Therapeutics' median Interest Coverage Ratio value was -3.21 (recorded in 2023), while the average stood at -3.28.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first soared by 100.65% in 2024, then slumped by 20,754.23% in 2025.
  • Aquestive Therapeutics' Interest Coverage Ratio (Quarterly) stood at -6.69 in 2021, then grew by 2.96% to -6.49 in 2022, then surged by 73.50% to -1.72 in 2023, then slumped by 183.98% to -4.89 in 2024, then plummeted by 38.52% to -4.13 in 2025.
  • Its Interest Coverage Ratio was -4.13 in Q3 2025, compared to -4.09 in Q2 2025 and -6.96 in Q1 2025.